News | December 16, 2024
Aster DM Healthcare launches precision oncology, offering data-driven, personalized cancer care
Harnessing advanced data analysis for early detection, prevention and better outcomes
Harnessing advanced data analysis for early detection, prevention and better outcomes
Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate
Aims to become India’s leading cancer testing company
GSK secures option to multiple high-value, validated Alzheimer’s-relevant targets for drug discovery, development, and commercialization
Designation was based on early efficacy data demonstrating an 83.3% (10/12) overall response rate and a 50% (6/12) complete response rate, with a well-managed safety profile in Relapsed/Refractory Hodgkin Lymphoma patients
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Subscribe To Our Newsletter & Stay Updated
